LivaNova (LIVN) Business Metric Overview - Stocknear

LivaNova

NASDAQ: LIVN · Real-Time Price · USD
57.97
-0.18 (-0.31%)
At close: Sep 05, 2025, 3:59 PM
57.97
0.00%
After-hours: Sep 05, 2025, 04:42 PM EDT

LivaNova Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cardiopulmonary Segment Revenue 199.27M 176.32M 181.67M 172.24M 173.71M 155.89M 161.47M 144.83M 150.6M 132.07M 136.46M 120.96M 125.82M 117.08M 121.55M 113.29M 117.64M 103.7M 109.17M 98.41M 57.21M 89.66M
Cardiopulmonary Segment Revenue Growth +13.02% -2.94% +5.47% -0.85% +11.43% -3.46% +11.50% -3.84% +14.03% -3.22% +12.82% -3.86% +7.47% -3.68% +7.29% -3.70% +13.44% -5.01% +10.93% +72.01% -36.19% n/a
Neuromodulation Segment Revenue 151.67M 138.89M 137.61M 139.86M 142.88M 133.87M 136.93M 128.88M 133.18M 120.72M 127.14M 121.83M 117.8M 110.23M n/a n/a n/a n/a n/a n/a n/a n/a
Neuromodulation Segment Revenue Growth +9.20% +0.93% -1.61% -2.11% +6.73% -2.23% +6.24% -3.23% +10.32% -5.04% +4.35% +3.43% +6.87% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Oct 18, 2015
Europe Revenue 66.78M 59.7M 61.62M 52.81M 51.26M 54.34M 62.56M 48.13M 54.46M 49.64M 74.78M 40M 47.37M 45.13M 48.95M 45.72M 56.04M 50.82M 54.76M 48.53M 35.36M 64.1M 12.12M -83.87M 92.95M 105.04M 96.35M 100.34M 91.25M 111.13M 99.31M 58.35M
Europe Revenue Growth +11.85% -3.11% +16.67% +3.04% -5.67% -13.14% +29.99% -11.62% +9.70% -33.61% +86.95% -15.57% +4.98% -7.81% +7.06% -18.41% +10.27% -7.20% +12.84% +37.24% -44.83% +429.04% -114.45% -190.23% -11.51% +9.02% -3.98% +9.97% -17.89% +11.91% +70.18% n/a
Locations Excluding The United States And Europe Revenue 97.27M 87.99M 85.11M 85.48M 87.78M 79.95M 74.35M 76.4M 79.45M 73.51M 46.31M 69.2M 68.69M 58.78M 71.29M 63.7M 64.1M 63.45M 76.79M 62.69M 68.66M 54.72M 6.54M 128.61M 122.21M 129.56M 114.35M 128.15M 123.81M 124.41M 114.13M n/a
Locations Excluding The United States And Europe Revenue Growth +10.55% +3.38% -0.42% -2.62% +9.79% +7.53% -2.68% -3.84% +8.08% +58.74% -33.08% +0.73% +16.86% -17.54% +11.91% -0.62% +1.03% -17.38% +22.49% -8.69% +25.48% +737.15% -94.92% +5.24% -5.67% +13.30% -10.77% +3.50% -0.48% +9.01% n/a n/a
United States Revenue 188.47M 169.16M 175.1M 179.83M 179.54M 160.62M 173.22M 161.58M 159.97M 140.27M 153.79M 143.41M 138.09M 136.27M 149.83M 143.79M 144.34M 133.34M 138M 128.86M 78.19M 123.58M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth +11.41% -3.39% -2.63% +0.16% +11.78% -7.27% +7.20% +1.01% +14.05% -8.79% +7.24% +3.86% +1.33% -9.05% +4.20% -0.38% +8.26% -3.38% +7.09% +64.81% -36.73% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Oct 18, 2015 Sep 30, 2015 Apr 30, 2015 Jan 31, 2015
Selling, General, and Administrative Revenue 137.78M 133.67M 135.62M 131.66M 129.12M 129.86M 133.3M 134.8M 125.9M 124.1M 119.6M 114.63M 116.5M 118.53M 124.4M 109.04M 122.75M 112.62M 110.3M 99.2M 98.05M 120.2M 130.6M 123.02M 127.21M 125.7M 122.2M 115.14M 123.4M 104.2M 101.6M 121.18M 120.37M 112.4M 123.5M 107.55M 120.2M 115.6M 41.19M 33.71M 30.41M 31.33M
Selling, General, and Administrative Revenue Growth +3.08% -1.44% +3.01% +1.97% -0.57% -2.58% -1.11% +7.07% +1.45% +3.76% +4.34% -1.61% -1.71% -4.72% +14.08% -11.17% +9.00% +2.10% +11.19% +1.17% -18.43% -7.96% +6.17% -3.30% +1.20% +2.87% +6.14% -6.70% +18.43% +2.56% -16.16% +0.67% +7.09% -8.99% +14.83% -10.52% +3.98% +180.68% +22.19% +10.82% -2.92% n/a
Research and Development Revenue 47.19M 37.88M 43.31M 48.8M 44.74M 41.86M 46.2M 46.5M 51.1M 50M 44.9M 35.73M 34.2M 40.92M 44.1M 42.13M 52.56M 44.63M 44.5M 47.37M 25.15M 35.9M 25.9M 45.9M 34.54M 43.58M 37.6M 42.42M 34.2M 31.8M 32.5M 31.39M 43.01M 29.65M 28.4M 32.17M 30.2M 31.7M 15.25M 10.06M 11.37M 10.53M
Research and Development Revenue Growth +24.57% -12.54% -11.26% +9.09% +6.86% -9.39% -0.65% -9.00% +2.20% +11.36% +25.68% +4.46% -16.42% -7.22% +4.67% -19.83% +17.77% +0.28% -6.05% +88.33% -29.94% +38.61% -43.58% +32.89% -20.73% +15.89% -11.36% +24.03% +7.55% -2.15% +3.53% -27.00% +45.04% +4.40% -11.73% +6.54% -4.73% +107.88% +51.56% -11.55% +8.02% n/a